Replies to post #204601 on Biotech Values

[ghmm]

GLPG / GILD:

The company said they couldn't comment on P3 trial till Gilead goes ahead... and then these appear today

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT02914522

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT02914535

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
https://clinicaltrials.gov/ct2/show/NCT02914561

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
https://clinicaltrials.gov/ct2/show/NCT02914600